|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||67.28 - 67.28|
|52-week range||67.28 - 67.28|
|Beta (5Y monthly)||0.86|
|PE ratio (TTM)||41.89|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Cerner (CERN) first-quarter results benefit from gains in Licensed software, Subscriptions and Professional and Managed services units, and international revenue growth.
Cerner (CERN) delivered earnings and revenue surprises of 5.97% and -1.20%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Medigate, an Israeli startup working to secure medical devices and manage assets inside a hospital, has partnered with the medical information technology juggernaut Cerner on services and support for the Israeli company's security software. Under the agreement, if customers work with Medigate, they'll receive support from Cerner's cybersecurity team to help with inventory of the devices in a location. Cerner will also offer remediation services to limit attacks if an organization has a security breach.
The healthcare technology provider met its revenue guidance and beat its adjusted earnings guidance, thanks primarily to growth in its services business.